Radiation InjuriesRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationAntineoplastic AgentsCombined Modality TherapyRadiation ProtectionRadiation OncologyRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedDose FractionationRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisNeoplasmsBrachytherapyTreatment OutcomeCell Line, TumorRadiometryRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalRadiosurgeryGamma RaysDrug Screening Assays, AntitumorCosmic RadiationRadiotherapy, Computer-AssistedBrain NeoplasmsCisplatinDoxorubicinCranial IrradiationParticle AcceleratorsNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedApoptosisRadiation-Protective AgentsTime FactorsHead and Neck NeoplasmsBackground RadiationRadiodermatitisCell SurvivalBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, High-EnergyNeoplasm StagingRetrospective StudiesUltraviolet RaysOrgans at RiskDNA DamageCobalt RadioisotopesDrug Resistance, NeoplasmProstatic NeoplasmsAntineoplastic Agents, PhytogenicRadiation EffectsCarcinoma, Squamous CellFollow-Up StudiesChemoradiotherapySurvival AnalysisRadiobiologyAdenocarcinomaTomography, X-Ray ComputedMice, NudeFluorouracilXenograft Model Antitumor AssaysDisease-Free SurvivalSurvival RateTumor Cells, CulturedAntibiotics, AntineoplasticTumor BurdenLung NeoplasmsX-RaysDrug Delivery SystemsMastectomy, SegmentalRelative Biological EffectivenessEtoposideChemotherapy, AdjuvantAcute Radiation SyndromePaclitaxelPrognosisLinear Energy TransferGlioblastomaDose-Response Relationship, DrugCell ProliferationClinical Trials as TopicDacarbazineDrug CarriersLymphatic IrradiationActuarial AnalysisRadioactive Hazard ReleaseFour-Dimensional Computed TomographyGliomaDNA RepairComparative Effectiveness ResearchRadiation Hybrid MappingVincristine